Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2023-04-14 to 2023-04-17
Current total value of award: $103.67
Description: 4560660301!GLIMEPIRIDE 4 MG TABLET UD 100S